BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8332291)

  • 1. Attitudes and practice of New Zealand doctors in the management of patients with dyslipidaemia.
    Bradley A; Elliott J; White H
    N Z Med J; 1993 Jun; 106(958):243-7. PubMed ID: 8332291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of implementation of the National Heart Foundation of New Zealand guidelines for the management of dyslipidaemia.
    Patel H; Neutze JM; Kerr B; White HD
    N Z Med J; 1996 Feb; 109(1015):24-6. PubMed ID: 8606809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cholesterol and coronary heart disease: Auckland general practitioners' attitudes and practices in 1986.
    Yates K; Jackson R; Tester P; Thompson A; Toledo J; Vamanamurthy R; Wong C
    N Z Med J; 1988 Feb; 101(840):76-8. PubMed ID: 3380436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Zealand guidelines for the management of dyslipidaemia: implications for treatment in an urban New Zealand population.
    North D; Priest P; Lay-Yee R; Jackson R
    N Z Med J; 1996 Apr; 109(1020):134-7. PubMed ID: 8649667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of elevated cholesterol levels by New Hampshire primary care physicians.
    Vivier PM; Dietrich AJ; Witters LA
    J Fam Pract; 1988 Aug; 27(2):167-72. PubMed ID: 3404101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitude changes of general practitioners towards lowering LDL cholesterol.
    Strandberg TE; Pitkänen A; Larjo P; Hirvonen P; Kohvakka A
    J Cardiovasc Risk; 1998 Feb; 5(1):43-6. PubMed ID: 9816555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General practitioners' tacit and stated policies in the prescription of lipid lowering agents.
    Evans JS; Harries C; Dennis I; Dean J
    Br J Gen Pract; 1995 Jan; 45(390):15-8. PubMed ID: 7779468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of physician's attitudes and practices toward lipid-lowering management strategies.
    Goldberg RJ; Rosen J; Roselli A; Lewis B
    Cardiology; 2007; 107(4):302-6. PubMed ID: 17264510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection and treatment of hyperlipidemia: physician practices in Canada.
    Tannenbaum TN; Sampalis JS; Battista RN; Rosenberg ER; Joseph L
    CMAJ; 1990 Nov; 143(9):875-81. PubMed ID: 2224715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of unstable angina and non-ST-elevation myocardial infarction: do cardiologists do it better? A comparison of secondary and tertiary centre management in New Zealand.
    Conaglen P; Sebastian C; Jayaraman C; Abraham A; Makkada V; Devlin G
    N Z Med J; 2004 May; 117(1194):U890. PubMed ID: 15156208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current standard of care in patients affected by coronary heart disease in Italy: the MC'95 study.
    Magnani B; Dal Palù C; Zanchetti A;
    Ital Heart J; 2002 Feb; 3(2):86-95. PubMed ID: 11926017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicians' perspectives on cholesterol and heart disease.
    O'Keefe CE; Hahn DF; Betts NM
    J Am Diet Assoc; 1991 Feb; 91(2):189-92. PubMed ID: 1991933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.
    Eur Heart J; 1987 Jan; 8(1):77-88. PubMed ID: 3816842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The change of attitude of Hungarian physicians towards the importance of risk factors of coronary heart disease over the period 1985-1996.
    Márk L; Nagy E; Kondacs A; Deli L
    Public Health; 1998 May; 112(3):197-201. PubMed ID: 9629028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observed changes in the lipid profile and calculated coronary risk in patients given dietary advice in primary care.
    Price D; Ramachandran S; Knight T; Jones PW; Neary RH
    Br J Gen Pract; 2000 Sep; 50(458):712-5. PubMed ID: 11050787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of dyslipidemias diagnosed in general practice in France--The PRAGMA Study].
    Amouyel P; Farnier M; Lyon G; Siest G; Mortier N; Amiot N; Duprat-Lomon I
    Arch Mal Coeur Vaiss; 2001 Oct; 94(10):1045-53. PubMed ID: 11725709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician management of hyperlipidemia in Saskatchewan: temporal trends and the effect of a CME program.
    Reeder BA; Horlick L; Laxdal OE
    Can J Cardiol; 1991 Nov; 7(9):385-90. PubMed ID: 1756417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.